Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With Chemoradiotherapy
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
This is an open, multicenter phase Ⅱ clinical trial on cetuximab (C225) combined with IMRT +
concurrent chemotherapy of cisplatin in locoregionally advanced nasopharyngeal carcinoma.
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Cancer Hospital of Guizhou Province Cancer Institute and Hospital, Chinese Academy of Medical Sciences Central South University First Affiliated Hospital of Guangxi Medical University Fudan University Fujian Cancer Hospital Sichuan Cancer Hospital and Research Institute